Maurizio Bonati is professor of public health at the Istituto di Ricerche Farmacologiche Mario Negri IRCSS in Milan, Italy.
Maurizio Bonati
Professor
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
From this contributor
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
By
Maurizio Bonati
7 May 2019 | 5 min read
Explore more from The Transmitter
Five new neuroscience books, and other notable titles from 2026
The Transmitter’s summer reading list includes an autopsy of the Human Brain Project, an overview of the neuroscience of motherhood and a memoir from a pioneer in Huntington’s disease research.
Five new neuroscience books, and other notable titles from 2026
The Transmitter’s summer reading list includes an autopsy of the Human Brain Project, an overview of the neuroscience of motherhood and a memoir from a pioneer in Huntington’s disease research.
By
Francisco J. Rivera Rosario
25 August 2026 | 7 min read
Biomarkers for autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 August.
Biomarkers for autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 August.
By
Jill Adams
25 August 2026 | 2 min read
How, when and why to use agentic AI in our neuroscience labs
With agentic AI’s rapid infiltration into science, researchers need to develop AI use policies and practices.
How, when and why to use agentic AI in our neuroscience labs
With agentic AI’s rapid infiltration into science, researchers need to develop AI use policies and practices.
By
Nicolas Schuck
24 August 2026 | 7 min read